
1. j clin microbiol. 2002 jun;40(6):1938-46.

multicenter evaluation new automated fourth-generation human
immunodeficiency virus screening assay sensitive antigen detection module 
and high specificity.

weber b(1), gürtler l, thorstensson r, michl u, mühlbacher a, bürgisser p,
villaescusa r, eiras a, gabriel c, stekel h, tanprasert s, oota s, silvestre mj, 
marques c, ladeira m, rabenau h, berger a, schmitt u, melchior w.

author information: 
(1)laboratoires réunis kutter-lieners-hastert, junglinster, luxembourg.
web@labo.lu

fourth-generation assays simultaneous detection human immunodeficiency
virus (hiv) antigen antibody available international market 
until antigen detection modules relatively poor sensitivity and
produce higher rate false-positive results third-generation enzyme
immunoassays (eias). new cobas core hiv combi eia improved
sensitivity hiv p24 antigen compared alternative fourth- and
third-generation assays, p24 antigen test, hiv type 1 (hiv-1) rna reverse
transcriptase pcr (rt-pcr). total 94 seroconversion panels (n = 709 sera),
samples acute phase infection seroconversion (n = 32),
anti-hiv-1-positive specimens (n = 730) patients different stages 
disease, 462 subtyped samples different geographical locations,
anti-hiv-2-positive sera (n = 302), dilutions cell culture supernatants (n =
62) cells infected different hiv-1 subtypes, selected performance
panels boston biomedica inc., 7,579 unselected samples blood donors,
303 unselected daily routine samples, 997 specimens hospitalized patients,
and potentially interfering samples (n = 1,222) tested cobas core hiv
combi eia. new assay showed sensitivity comparable abbott
hiv-1 ag monoclonal early detection hiv infection seroconversion
panels. mean time delay cobas core hiv combi eia (last negative sample
plus 1 day) comparison hiv-1 rt-pcr 87 panels tested both
methods 2.75 days. diagnostic window reduced cobas core hiv
combi eia 3.6 5.7 days third-generation assays. 
specificities cobas core hiv combi eia blood donors 99.84 99.85%
(after repeated testing). overall, 30 repeatedly reactive false-positive results 
out 10,031 hiv-negative samples obtained cobas core hiv combi eia.
our results show fourth-generation assay improved specificity as
cobas core hiv combi eia suitable blood donor screening low
number false positives detects hiv p24 antigen a
sensitivity comparable single-antigen assays.

doi: 10.1128/jcm.40.6.1938-1946.2002 
pmcid: pmc130745
pmid: 12037046  [indexed medline]

